Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial. (Q43152545)

From Wikidata
Jump to: navigation, search
scientific article published on 23 February 2010
edit
Language Label Description Also known as
English
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.
scientific article published on 23 February 2010

    Statements

    Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial. (English)
    0 references
    Nigel J Bundred
    Angela Cramer
    Julie Morris
    Lorna Renshaw
    Kwok-Leung Cheung
    Pamela Flint
    Rachael Johnson
    Oliver Young
    Göran Landberg
    Sue Grassby
    Lorraine Turner
    Andrew Baildam
    J Michael Dixon
    23 February 2010
    1605-1612

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit